Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BXP.L Stock Summary
Top 10 Correlated ETFs
BXP.L
In the News
BXP.L Financial details
Company Rating
Buy
Market Cap
185.14M
Income
4.61B
Revenue
39.27B
Book val./share
-
Cash/share
-
Dividend
0.03
Dividend %
0.08%
Employees
5.5K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
5.53
Forward P/E
-
PEG
-1.9
P/S
0.65
P/B
0.58
P/C
-
P/FCF
9.46
Quick Ratio
0.09
Current Ratio
1.57
Debt / Equity
0.24
LT Debt / Equity
0.05
-
-
EPS (TTM)
8.14
EPS next Y
-
EPS next Q
-
EPS this Y
-9.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.74%
Revenue last 5Y
11.47%
Revenue Q/Q
5.02%
EPS Q/Q
-
-
-
-
-
SMA20
5.13%
SMA50
5.13%
SMA100
10.81%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
11%
ROC
0.13%
Gross Margin
44%
Oper. Margin
18%
Profit Margin
12%
Payout
34%
Shs Outstand
1.13B
Shs Float
297.32M
-
-
-
-
Target Price
-
52W Range
33.3-60.0
52W High
-30.83%
52W Low
+25.76%
RSI
61
Rel Volume
64.41
Avg Volume
59.77K
Volume
3.85M
Perf Week
2.47%
Perf Month
7.79%
Perf Quarter
16.9%
Perf Half Y
9.21%
-
-
-
-
Beta
0.65
-
-
Volatility
0.36%, 1.26%
Prev Close
0%
Price
41.5
Change
-
BXP.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 51.15 | 57.44 | 66.11 | 77.71 | 88 | |
Net income per share | 6.8 | 7.88 | 11.49 | 11.48 | 10.34 | |
Operating cash flow per share | 6.63 | 12.43 | 0 | 12.31 | 13.64 | |
Free cash flow per share | -3.55 | 7.33 | -5.73 | 5.72 | 7.56 | |
Cash per share | 2.09 | 1.42 | 1.51 | 2.62 | 2.55 | |
Book value per share | 66.32 | 72.87 | 83.01 | 91.01 | 97.89 | |
Tangible book value per share | 62.73 | 69.46 | 79.44 | 88.32 | 94.62 | |
Share holders equity per share | 66.32 | 72.87 | 83.01 | 91.01 | 97.89 | |
Interest debt per share | 32.54 | 25.83 | 19.03 | 29.98 | 26.66 | |
Market cap | 16.23B | 14.88B | 44.06B | 34.79B | 21.35B | |
Enterprise value | 29.1B | 24.75B | 51.02B | 45.99B | 30.83B | |
P/E ratio | 5.35 | 4.23 | 8.59 | 6.79 | 4.63 | |
Price to sales ratio | 0.71 | 0.58 | 1.49 | 1 | 0.54 | |
POCF ratio | 5.48 | 2.68 | 0 | 6.33 | 3.51 | |
PFCF ratio | -10.24 | 4.55 | -17.22 | 13.62 | 6.33 | |
P/B Ratio | 0.55 | 0.46 | 1.19 | 0.86 | 0.49 | |
PTB ratio | 0.55 | 0.46 | 1.19 | 0.86 | 0.49 | |
EV to sales | 1.28 | 0.97 | 1.73 | 1.33 | 0.79 | |
Enterprise value over EBITDA | 5.85 | 4.37 | 7.05 | 5.98 | 4.19 | |
EV to operating cash flow | 9.83 | 4.46 | 0 | 8.37 | 5.07 | |
EV to free cash flow | -18.36 | 7.57 | -19.94 | 18.01 | 9.14 | |
Earnings yield | 0.19 | 0.24 | 0.12 | 0.15 | 0.22 | |
Free cash flow yield | -0.1 | 0.22 | -0.06 | 0.07 | 0.16 | |
Debt to equity | 0.46 | 0.32 | 0.21 | 0.3 | 0.24 | |
Debt to assets | 0.27 | 0.21 | 0.15 | 0.19 | 0.15 | |
Net debt to EBITDA | 2.59 | 1.74 | 0.96 | 1.46 | 1.29 | |
Current ratio | 1.04 | 1.15 | 1.47 | 1.45 | 1.57 | |
Interest coverage | 4.92 | 5.53 | 7.75 | 6.89 | 5.61 | |
Income quality | 0 | 0 | 0 | 1.07 | 0 | |
Dividend Yield | 0.03 | 0.04 | 0.01 | 0.05 | 0.07 | |
Payout ratio | 0.17 | 0.17 | 0.11 | 0.32 | 0.34 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Research and developement to revenue | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.08 | 0.08 | |
Capex to operating cash flow | -1.54 | -0.41 | 0 | -0.54 | -0.45 | |
Capex to revenue | -0.2 | -0.09 | -0.09 | -0.08 | -0.07 | |
Capex to depreciation | 0 | 0 | 0 | -7.94 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 100.73 | 113.68 | 146.52 | 153.35 | 150.91 | |
ROIC | 0.09 | 0.1 | 0.12 | 0.1 | 0.1 | |
Return on tangible assets | 0.06 | 0.07 | 0.1 | 0.08 | 0.07 | |
Graham Net | -33.83 | -29.88 | -15.53 | -51.84 | -31.21 | |
Working capital | 518.33M | 1.69B | 4.42B | 5.68B | 7.61B | |
Tangible asset value | 27.98B | 30.98B | 35.44B | 39.4B | 42.22B | |
Net current asset value | -6.09B | -4.27B | -1.11B | -3.09B | -661.26M | |
Invested capital | 0.46 | 0.32 | 0.21 | 0.3 | 0.24 | |
Average receivables | 0 | 0 | 2.25B | -3.31B | -5.56B | |
Average payables | 1.04B | 1.28B | 1.71B | 2.22B | 3B | |
Average inventory | 6.19B | 6.69B | 7.26B | 9.46B | 12.04B | |
Days sales outstanding | 0 | 0 | 55.71 | -117.12 | 0 | |
Days payables outstanding | 32.67 | 38.94 | 46.07 | 47.72 | 58.72 | |
Days of inventory on hand | 199.02 | 178.88 | 182.96 | 215.34 | 215.36 | |
Receivables turnover | 0 | 0 | 6.55 | -3.12 | 0 | |
Payables turnover | 11.17 | 9.37 | 7.92 | 7.65 | 6.22 | |
Inventory turnover | 1.83 | 2.04 | 1.99 | 1.69 | 1.69 | |
ROE | 0.1 | 0.11 | 0.14 | 0.13 | 0.11 | |
Capex per share | -10.19 | -5.1 | -5.73 | -6.59 | -6.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q4
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 19.59 | 21.94 | 22.17 | 21.42 | 0 | |
Net income per share | 1.89 | 3.24 | 2.77 | 2.13 | 0 | |
Operating cash flow per share | 2.18 | 3.24 | 2.77 | 2.13 | 0 | |
Free cash flow per share | -0.29 | 1.71 | 1.22 | 1.01 | 0 | |
Cash per share | 2.62 | 1.96 | 2.79 | 2.21 | 0 | |
Book value per share | 91.01 | 94.25 | 93.52 | 95.65 | 0 | |
Tangible book value per share | 88.32 | 91.73 | 91.03 | 93.05 | 0 | |
Share holders equity per share | 91.01 | 94.25 | 93.52 | 95.65 | 0 | |
Interest debt per share | 28.38 | 27.62 | 26.53 | 26.25 | 0 | |
Market cap | 34.79B | 34.39B | 30.42B | 22.08B | 0 | |
Enterprise value | 45.99B | 45.53B | 40.67B | 32.48B | 9.48B | |
P/E ratio | 10.32 | 5.94 | 6.15 | 5.81 | 0 | |
Price to sales ratio | 3.98 | 3.51 | 3.08 | 2.31 | 0 | |
POCF ratio | 35.76 | 23.76 | 24.59 | 23.22 | 0 | |
PFCF ratio | -269.39 | 44.97 | 56 | 49.11 | 0 | |
P/B Ratio | 0.86 | 0.82 | 0.73 | 0.52 | 0 | |
PTB ratio | 0.86 | 0.82 | 0.73 | 0.52 | 0 | |
EV to sales | 5.26 | 4.65 | 4.11 | 3.4 | 0.94 | |
Enterprise value over EBITDA | 35.52 | 20.76 | 20.45 | 20.99 | 5.83 | |
EV to operating cash flow | 47.27 | 31.46 | 32.88 | 34.17 | 5.34 | |
EV to free cash flow | -356.14 | 59.54 | 74.88 | 72.27 | 10.07 | |
Earnings yield | 0.02 | 0.04 | 0.04 | 0.04 | 0 | |
Free cash flow yield | 0 | 0.02 | 0.02 | 0.02 | 0 | |
Debt to equity | 0.3 | 0.29 | 0.28 | 0.27 | 0.24 | |
Debt to assets | 0.19 | 0.18 | 0.17 | 0.17 | 0.15 | |
Net debt to EBITDA | 8.65 | 5.08 | 5.16 | 6.72 | 5.83 | |
Current ratio | 1.45 | 1.59 | 1.47 | 1.58 | 1.57 | |
Interest coverage | 4.05 | 6.79 | 5.92 | 4.77 | 5 | |
Income quality | 1.15 | 1 | 1 | 1 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0.07 | 0 | |
Payout ratio | 0.01 | 0 | 0 | 1.63 | 0.01 | |
Sales general and administrative to revenue | 0.11 | 0.03 | 0.03 | 0.04 | 0.02 | |
Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.08 | 0.08 | 0.07 | 0.07 | 0.08 | |
Capex to operating cash flow | -1.13 | -0.47 | -0.56 | -0.53 | -0.47 | |
Capex to revenue | -0.13 | -0.07 | -0.07 | -0.05 | -0.08 | |
Capex to depreciation | -8.46 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 62.19 | 82.94 | 76.39 | 67.72 | 0 | |
ROIC | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | |
Graham Net | -28.15 | -26.64 | -29.47 | -32.64 | 0 | |
Working capital | 5.68B | 7.32B | 6.85B | 7.62B | 7.61B | |
Tangible asset value | 39.4B | 40.92B | 40.61B | 41.51B | 42.22B | |
Net current asset value | -3.09B | -1.8B | -2.32B | -1.36B | -661.26M | |
Invested capital | 0.3 | 0.29 | 0.28 | 0.27 | 0.24 | |
Average receivables | 3.55B | 3.11B | 3.27B | 1.65B | 0 | |
Average payables | 2.69B | 2.5B | 2.91B | 3.38B | 3.5B | |
Average inventory | 10.87B | 11.8B | 12.96B | 13.39B | 13.15B | |
Days sales outstanding | 30.51 | 29.86 | 30.02 | 0 | 0 | |
Days payables outstanding | 43.11 | 42.64 | 54.2 | 58.46 | 54.8 | |
Days of inventory on hand | 194.56 | 209.31 | 221.95 | 224.91 | 201 | |
Receivables turnover | 2.95 | 3.01 | 3 | 0 | 0 | |
Payables turnover | 2.09 | 2.11 | 1.66 | 1.54 | 1.64 | |
Inventory turnover | 0.46 | 0.43 | 0.41 | 0.4 | 0.45 | |
ROE | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
Capex per share | -2.47 | -1.53 | -1.56 | -1.12 | 0 |
BXP.L Frequently Asked Questions
What is Beximco Pharmaceuticals Limited stock symbol ?
Beximco Pharmaceuticals Limited is a BD stock and trading under the symbol BXP.L
What is Beximco Pharmaceuticals Limited stock quote today ?
Beximco Pharmaceuticals Limited stock price is $41.5 today.
Is Beximco Pharmaceuticals Limited stock public?
Yes, Beximco Pharmaceuticals Limited is a publicly traded company.